The James Buchanan Brady Urological Institute
 
 
 
Daniel W. Chan, Ph.D. Daniel W. Chan, Ph.D., DABCC, FACB

Professor, Pathology, Oncology, Urology, and Radiology
Johns Hopkins Medical Institutions

Director, Clinical Chemistry Division and Co-Director, Pathology Core Lab.
Department of Pathology

Director, Center for Biomarker Discovery
The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA


PATENTS (Filed and pending)

  • Identification of Biomarkers For Ovarian Cancer
  • Identification of Biomarkers For breast Cancer
  • Identification of Biomarkers For Prostate Cancer
  • Biomarkers for the Detection of Pancreatic Cancer
  • A Novel Process for Biomarker Discovery and Validation Using Bioinformatics and SELDI Mass-spectrometry-based Protein Expression Profiling
  • Protein Identification and Validation of Serum Markers for Early Detection of Breast Cancer
  • Identification of Biomarkers in Breast Fluid for Breast Cancer
  • Variants of Hepcidin as Biomarker for Ovarian Cancer
  • Protein C Inhibitor (PCI) and C4a as Biomarkers for Prostate Cancer
  •  Biomarkers for Chemo-resistance in Ovarian Cancer




© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.| Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287